Literature DB >> 12594257

CD7 is a differentiation marker that identifies multiple CD8 T cell effector subsets.

Einar M Aandahl1, Johan K Sandberg, Karen P Beckerman, Kjetil Taskén, Walter J Moretto, Douglas F Nixon.   

Abstract

The adaptive immune response of human CD8 T cells to invading pathogens involves the differentiation of naive cells into memory and effector cells. However, the lineage relationship between memory and effector cells and the differentiation of CD8 T cells into distinct subsets of effector cell subpopulations are subjects of considerable debate. CD7 identifies three populations of CD8 T cells: CD7 high (CD7(high)), low (CD7(low)), and negative (CD7(neg)) that translate into subsets with distinct functional properties. The CD7(high) subset contains naive and memory cells and the CD7(low) and CD7(neg) subsets contain effector cells. The effector cells can functionally be divided into cytokine-secreting effector CD8 T cells and lytic effector CD8 T cells. These data provide a model of human CD8 T cell differentiation in which specialized distinct subpopulations can be identified by expression of CD7.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594257     DOI: 10.4049/jimmunol.170.5.2349

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsets.

Authors:  Veronica D Gonzalez; Niklas K Björkström; Karl-Johan Malmberg; Markus Moll; Carlotta Kuylenstierna; Jakob Michaëlsson; Hans-Gustaf Ljunggren; Johan K Sandberg
Journal:  J Immunol Methods       Date:  2007-12-04       Impact factor: 2.303

3.  Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes.

Authors:  Iole Macchia; Marie-Claire Gauduin; Amitinder Kaur; R Paul Johnson
Journal:  Immunology       Date:  2006-07-12       Impact factor: 7.397

4.  Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies.

Authors:  Yi Tian Png; Natasha Vinanica; Takahiro Kamiya; Noriko Shimasaki; Elaine Coustan-Smith; Dario Campana
Journal:  Blood Adv       Date:  2017-11-21

5.  Functional profile of human influenza virus-specific cytotoxic T lymphocyte activity is influenced by interleukin-2 concentration and epitope specificity.

Authors:  A C M Boon; G de Mutsert; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

6.  Effector CD8+ T cells recovered from an influenza pneumonia differentiate to a state of focused gene expression.

Authors:  Dana R Marshall; Elvia Olivas; Samita Andreansky; Nicole L La Gruta; Geoff A Neale; Astrid Gutierrez; David G Wichlan; Suzette Wingo; Cheng Cheng; Peter C Doherty; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-14       Impact factor: 11.205

7.  Epitope-specific CD8+ T lymphocytes cross-recognize mutant simian immunodeficiency virus (SIV) sequences but fail to contain very early evolution and eventual fixation of epitope escape mutations during SIV infection.

Authors:  Evan M Cale; Peter Hraber; Elena E Giorgi; Will Fischer; Tanmoy Bhattacharya; Thomas Leitner; Wendy W Yeh; Cheryl Gleasner; Lance D Green; Cliff S Han; Bette Korber; Norman L Letvin
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

8.  Theileria parva candidate vaccine antigens recognized by immune bovine cytotoxic T lymphocytes.

Authors:  Simon P Graham; Roger Pellé; Yoshikazu Honda; Duncan M Mwangi; Nyerhovwo J Tonukari; Mat Yamage; E Jane Glew; Etienne P de Villiers; Trushar Shah; Richard Bishop; Evelyne Abuya; Elias Awino; James Gachanja; Anthony E Luyai; Ferdinand Mbwika; Anthony M Muthiani; David M Ndegwa; Moses Njahira; John K Nyanjui; Fredrick O Onono; Julius Osaso; Rosemary M Saya; Claude Wildmann; Claire M Fraser; Ian Maudlin; Malcolm J Gardner; Subhash P Morzaria; Sheena Loosmore; Sarah C Gilbert; Jean-Christophe Audonnet; Pierre van der Bruggen; Vishvanath Nene; Evans L N Taracha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

9.  Phenotypical and potential functional characteristics of different immune cells expressing CD28H/B7-H5 and their relationship with cancer prognosis.

Authors:  C Zhong; Q Lang; J Yu; S Wu; F Xu; Y Tian
Journal:  Clin Exp Immunol       Date:  2020-02-04       Impact factor: 4.330

10.  Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.

Authors:  S Oberbeck; A Schrader; K Warner; D Jungherz; G Crispatzu; J von Jan; M Chmielewski; A Ianevski; H H Diebner; P Mayer; A Kondo Ados; L Wahnschaffe; T Braun; T A Müller; P Wagle; A Bouska; T Neumann; S Pützer; L Varghese; N Pflug; M Thelen; J Makalowski; N Riet; H J M Göx; G Rappl; J Altmüller; M Kotrová; T Persigehl; G Hopfinger; M L Hansmann; H Schlößer; S Stilgenbauer; J Dürig; D Mougiakakos; M von Bergwelt-Baildon; I Roeder; S Hartmann; M Hallek; R Moriggl; M Brüggemann; T Aittokallio; J Iqbal; S Newrzela; H Abken; M Herling
Journal:  Blood       Date:  2020-12-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.